Related Experiment Video

Updated: Aug 18, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 10, 2011

[Pathogenicity of methicillin resistant Staphylococcus aureus. In vitro study]

P Vaudaux, F A Waldvogel

    Schweizerische Medizinische Wochenschrift
    |December 4, 1976
    PubMed

    Insights

    Methicillin-resistant Staphylococcus aureus (MRSA) strains exhibit greater survival against human immune cells (polymorphonuclear leukocytes) in laboratory tests. This enhanced pathogenicity is independent of their antibiotic resistance levels.

    Area of Science:

    • Microbiology
    • Immunology
    • Infectious Diseases

    Context:

    • Assessing the pathogenicity of methicillin-resistant Staphylococcus aureus (MRSA) is challenging using traditional clinical or epidemiological data.
    • Polymorphonuclear leukocytes (PMN) are crucial in combating S. aureus infections, making them ideal for in vitro pathogenicity studies.

    Purpose:

    • To evaluate the in vitro pathogenicity of methicillin-resistant (MR) S. aureus strains compared to methicillin-sensitive (MetS) strains using a phagocytic assay.
    • To determine if increased antibiotic resistance influences the pathogenic potential of MR strains.

    Summary:

    • An in vitro phagocytic assay was conducted using isolated PMN to compare the survival rates of MR and MetS S. aureus strains.
    • MR strains demonstrated significantly better survival against PMN phagocytosis than MetS strains after 30 and 60 minutes of incubation.
    • Amplifying antibiotic resistance in three MR strains did not alter their survival rates in the phagocytic assay.

    Impact:

    • Methicillin-resistant S. aureus strains possess inherent pathogenic potential.
    • The level of methicillin resistance does not appear to affect the intrinsic pathogenicity of S. aureus strains in this phagocytic model.

    More Related Videos

    Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes12:27

    Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

    Published on: January 3, 2020

    Development and Assessment of Intracellular Infection Models for Staphylococcus aureus08:32

    Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

    Published on: January 17, 2025

    Related Concept Videos

    Staphylococcal Skin Infections01:29

    Staphylococcal Skin Infections

    Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
    Clinical Significance of Antibiotic Resistance01:25

    Clinical Significance of Antibiotic Resistance

    Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...